SUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapy

By afschroeder • October 27, 2026

Chaft J, Lee JM, Senan S, Neal JW, Nadal E, Negrao MV, Popat S, Garassino MC, Gray JE, Lee SH, Mazieres J, Thomas M, Benes M, Liu H, Liu J, Ma QL, Segall G, Puri T, Wu YL. SUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapy. Future Oncol. 2026 Sep;22(22):2673-2682. doi: 10.1080/14796694.2026.2736401. Epub 2026 Oct 1. PMID: 42823821.

Tags: adjuvant therapy, KRAS G12C, NSCLC, olomorasib, Publications, Pulmonary, Critical Care & Sleep Medicine, study design

Paget Disease of the Calvarium: A Case Report

Navabi K, Patel E. Paget Disease of the Calvarium: A Case Report. Cureus. 2026 Sep 25;18(9):e116917. doi: 10.7759/cureus.116917. PMID: 42928824; PMCID: PMC13695978.

Frailty Is Associated With Lower Urinary Tract Symptoms in Adults With and Without HIV

Abelman RA, Ma Y, Margolick JB, Erlandson KM, Greene M, Suskind AM, Taylor T, Rinaldo CR, Floris-Moore M, Chew KW, French AL, Markland AD, Stosor[...]

Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder Cancer

Powles T, Grande E, Simone G, Gómez de Liaño A, Maruzzo M, Velho PI, Kikuchi E, Vu TQ, Popovic L, Çil T, Gravis G, Radkowski[...]